Shots:
- Pfizer launched a pilot program to support the state’s planning, deployment & administration of the COVID-19 vaccine candidate, to build on coordination with the relevant US agencies
- Pfizer has been working with US officials in OWS & the US CDC to help ensure that after potential authorization or approval, the Pfizer-bioNtech COVID-19 vaccine can reach those in most need as quickly and equitably as possible
- The BNT162b2 COVID-19 vaccine is not currently approved for distribution anywhere in the world, both collaborators are committed to developing these novel vaccines with preclinical & clinical data at the forefront of all their decision making
Click here to read full press release/ article | Ref: Pfizer | Image: Pfizer
The post Pfizer Launches US Pilot Programme for Delivery and Distribution of COVID-19 Vaccine, BNT162b2 first appeared on PharmaShots.
